Use promo code GOBLUE to receive an exclusive discount

Studying an Extra COVID-19 Vaccine Dose in People with Autoimmune Diseases

September 1, 2021

 • 

Read time:

5-15 mins
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Nurse Holding Syringe Vials Vaccine 0 Gatewayextension
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Presented by Health Lab

Immunocompromised people make up less than three percent of the United States adult population. However, they account for forty-five percent of breakthrough COVID-19 infections. The Centers for Disease Control and Prevention recommended that people who are moderately to severely immunocompromised get a third dose of the COVID-19 vaccine. A team of researchers at Michigan Medicine will co-lead a national trial to determine the effectiveness of a third dose.

More from the Alumni Education Gateway
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.